Xiang Huang

2.5k total citations
114 papers, 1.7k citations indexed

About

Xiang Huang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiang Huang has authored 114 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 38 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiang Huang's work include RNA modifications and cancer (12 papers), HER2/EGFR in Cancer Research (12 papers) and Meningioma and schwannoma management (10 papers). Xiang Huang is often cited by papers focused on RNA modifications and cancer (12 papers), HER2/EGFR in Cancer Research (12 papers) and Meningioma and schwannoma management (10 papers). Xiang Huang collaborates with scholars based in China, United States and South Korea. Xiang Huang's co-authors include Ziyi Fu, Yongmei Yin, Chunxiao Sun, Fan Yang, Shiyun Cui, Hao Wu, Jiahui Chu, Yongfei Li, Yanhong Zhang and Longbang Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Hepatology.

In The Last Decade

Xiang Huang

111 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Huang China 24 848 517 372 244 183 114 1.7k
Pan Wang China 28 1.1k 1.3× 660 1.3× 432 1.2× 200 0.8× 287 1.6× 179 2.2k
Yuan Tan China 22 926 1.1× 308 0.6× 255 0.7× 434 1.8× 234 1.3× 57 1.7k
Song Han United States 24 707 0.8× 216 0.4× 263 0.7× 212 0.9× 238 1.3× 81 1.8k
Sheng Zhang China 25 785 0.9× 232 0.4× 265 0.7× 432 1.8× 91 0.5× 116 1.6k
Michele Reibaldi Italy 35 950 1.1× 266 0.5× 175 0.5× 182 0.7× 321 1.8× 258 4.3k
Hailong Liu China 22 661 0.8× 228 0.4× 229 0.6× 93 0.4× 184 1.0× 93 1.6k
Salvatore Raffa Italy 26 1.0k 1.2× 531 1.0× 426 1.1× 486 2.0× 194 1.1× 79 2.1k
Bret M. Evers United States 23 963 1.1× 198 0.4× 475 1.3× 233 1.0× 253 1.4× 89 2.0k
Yuko Ito Japan 28 1.4k 1.6× 756 1.5× 226 0.6× 426 1.7× 281 1.5× 103 2.3k

Countries citing papers authored by Xiang Huang

Since Specialization
Citations

This map shows the geographic impact of Xiang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Huang more than expected).

Fields of papers citing papers by Xiang Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Huang. The network helps show where Xiang Huang may publish in the future.

Co-authorship network of co-authors of Xiang Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Huang. A scholar is included among the top collaborators of Xiang Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Huang. Xiang Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ting, et al.. (2025). PRDX1 affects acrylamide-induced neural damage through the PTEN/AKT signaling pathway. NeuroToxicology. 108. 150–158. 1 indexed citations
2.
Sun, Chunxiao, Fan Yang, Yanting Sun, et al.. (2025). Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer. eLife. 14. 2 indexed citations
3.
Huang, Xiang, Nan Jin, Chunxiao Sun, et al.. (2024). Abstract PO1-04-04: Inetetamab combined with pyrotinib and oral vinorelbine for patients with HER2-positive metastatic breast cancer: a single-arm phase 2 trial. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
4.
Wang, Jialiang, Xiang Huang, Yanfei Zhou, et al.. (2024). CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer. BMC Medical Imaging. 24(1). 45–45. 8 indexed citations
5.
Yang, Cheng‐Wei, et al.. (2024). Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167129–167129. 4 indexed citations
6.
Gao, Hongfei, Min Yan, Qianjun Chen, et al.. (2023). Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China. Cancers. 15(17). 4360–4360. 2 indexed citations
7.
Cao, Zhigang, Xiang Huang, & Feixiang Chen. (2023). Diagnostic values of glial fibrillary acidic protein, neuron-specific enolase and protein S100β for sepsis-associated encephalopathy. SHILAP Revista de lepidopterología. 31(2). 107–112. 1 indexed citations
8.
Huang, Xiang, et al.. (2023). CircIQGAP1 regulates RCAN1 and RCAN2 through the mechanism of ceRNA and promotes the growth of malignant glioma. Pharmacological Research. 197. 106979–106979. 5 indexed citations
9.
Sun, Chunxiao, Xiang Huang, Jun Li, et al.. (2023). Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer. Cancers. 15(3). 899–899. 23 indexed citations
10.
Huang, Xiang, et al.. (2023). IDDF2023-ABS-0255 Ace2 deficiency promotes colorectal cancer by remodeling gut microbiota. A119.1–A119. 1 indexed citations
11.
Yang, Xue, Chun Gu, Feiyang Li, et al.. (2023). Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis. Redox Biology. 69. 103002–103002. 15 indexed citations
12.
Li, Wěi, Dongyan Cai, Chunxiao Sun, et al.. (2022). Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study. Therapeutic Advances in Medical Oncology. 14. 4287497264–4287497264. 5 indexed citations
13.
Wang, Xi, Tianyu Zeng, Fan Yang, et al.. (2021). Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study. Cancer Medicine. 10(23). 8662–8672. 14 indexed citations
14.
Yang, Fan, Tianyu Zeng, Chunxiao Sun, et al.. (2021). Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. Journal of Experimental & Clinical Cancer Research. 40(1). 142–142. 31 indexed citations
15.
Zeng, Tianyu, Chunxiao Sun, Yuchen Zhang, et al.. (2020). Relationship between tRNA‐derived fragments and human cancers. International Journal of Cancer. 147(11). 3007–3018. 44 indexed citations
16.
17.
18.
Yang, Fan, Ziyi Fu, Mengzhu Yang, et al.. (2019). Expression pattern of microRNAs related with response to trastuzumab in breast cancer. Journal of Cellular Physiology. 234(9). 16102–16113. 9 indexed citations
19.
Chen, Jing, Xiang Huang, Guichun Huang, et al.. (2012). Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model. Cancer Biotherapy and Radiopharmaceuticals. 27(3). 210–220. 40 indexed citations
20.
Chen, Longbang, et al.. (2009). The Antitumor Effects of CIK Cells Combined with Docetaxel Against Drug-Resistant Lung Adenocarcinoma Cell Line SPC-A1/DTX in Vitro and in Vivo. Cancer Biotherapy and Radiopharmaceuticals. 24(1). 91–98. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pan Wang Breakdown of academic impact, for papers by Yuan Tan Breakdown of academic impact, for papers by Song Han Breakdown of academic impact, for papers by Sheng Zhang Breakdown of academic impact, for papers by Michele Reibaldi Breakdown of academic impact, for papers by Hailong Liu Breakdown of academic impact, for papers by Salvatore Raffa Breakdown of academic impact, for papers by Bret M. Evers Breakdown of academic impact, for papers by Yuko Ito
Rankless by CCL
2026